Literature DB >> 2541841

Thrombocytopenia and angiotensin converting enzyme inhibitors.

J F Ackroyd1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541841      PMCID: PMC1836177          DOI: 10.1136/bmj.298.6678.964-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Quinidine-induced thrombocytopenic purpura complicating dicumarol therapy.

Authors:  R D GITTLER; M KISSIN; J LITWINS
Journal:  Ann Intern Med       Date:  1955-05       Impact factor: 25.391

2.  Quinidine-induced thrombocytopenic purpura; report of a fourteenth case and review of clinical and experimental studies.

Authors:  L WEISFUSE; P W SPEAR; M SASS
Journal:  Am J Med       Date:  1954-09       Impact factor: 4.965

3.  Thrombocytopenia induced by angiotensin converting enzyme inhibitors.

Authors:  B Grosbois; D Milton; C Beneton; D Jacomy
Journal:  BMJ       Date:  1989-01-21

4.  Captopril associated isolated thrombocytopenia.

Authors:  M A Khan; S A Bashi; M S Noah
Journal:  Ir Med J       Date:  1987-03

5.  Reversible severe thrombocytopaenia associated with captopril therapy.

Authors:  K P Walsh; J Branagan; M J Walsh
Journal:  Ir Med J       Date:  1986-02

Review 6.  [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].

Authors:  P Solal-Céligny; C Benichou; P Boivin; A Castot; L Coulombel; G Danan; L Degos; J C Evreux; G Lagier; J Lavarenne
Journal:  Nouv Rev Fr Hematol       Date:  1987
  6 in total
  1 in total

Review 1.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.